Diagnostic Tools

Valsalva test

Valsalva Maneuver Test · Z01.89

The Valsalva maneuver test is a non-invasive autonomic nerve function test that analyzes the autonomic response of heart rate and blood pressure by increasing intrathoracic pressure through forced expiration. It is a standard autonomic nerve test that simultaneously evaluates sympathetic and parasympathetic nerve functions.

AT A GLANCE

At a glance

The Valsalva maneuver analyzes the pattern of heart rate and blood pressure changes during and immediately after performing the motion of covering the mouth or nose and blowing hard (maintaining intrathoracic pressure of 40 mmHg for 15 seconds). Valsalva ratio is an indicator of parasympathetic nerve function, and delay or loss of blood pressure response suggests abnormal sympathetic nerve function. It is a core item of the autonomic function battery, which is essential for the evaluation of diabetic autonomic neuropathy, autonomic dysfunction, multiple system atrophy, and peripheral neuropathy.

Definition and Overview

The Valsalva maneuver is a movement that increases intrathoracic pressure by covering the mouth or nose and performing forced exhalation. Since its description by Italian anatomist Antonio Maria Valsalva (1666-1723), it has been widely used in clinical medicine and physiological research.

The Valsalva maneuver test is a standard autonomic function test that simultaneously evaluates sympathetic and parasympathetic nerve functions by analyzing the pattern of changes in heart rate and blood pressure that occur during this movement. It is recommended as a standard item for evaluating autonomic function by the American Academy of Neurology (AAN) and the American Diabetes Association (ADA).

physiological principles

The Valsalva maneuver consists of four steps.

Phase I: As soon as forced exhalation begins, the aorta is compressed due to an increase in intrathoracic pressure, causing a temporary increase in blood pressure. Heart rate decreases reflexively.

Phase II: Venous return decreases as intrathoracic pressure continues to rise. As cardiac output decreases, blood pressure gradually falls. To compensate for this, the sympathetic nerves are activated, the heart rate increases, and peripheral blood vessels constrict. Phase 2 is subdivided into early (IIa) and late (IIb). As sympathetic nerve activity increases in IIb, blood pressure begins to recover.

Phase III: Immediately after forced expiration ends, intrathoracic pressure suddenly decreases and venous blood flows into the lungs, resulting in a temporary drop in blood pressure.

Phase IV: Blood pressure overshoots due to normalization of venous return and vasoconstriction effects. As a baroreceptor response to this increase in blood pressure, the parasympathetic nerves are activated and the heart rate decreases.

Valsalva Ratio

Valsalva ratio (VR) is the maximum heart rate during the exercise divided by the minimum heart rate after the exercise.

VR = maximum heart rate during manipulation / minimum heart rate after manipulation

VR is a representative indicator of parasympathetic nerve function, and normal values vary depending on age. In general, VR ≥ 1.50 is the normal range in young adults, and the lower normal limit decreases with age. Anything below 1.20 is considered an abnormal finding.

According to research, VR shows an inverse correlation with the duration of diabetes and the level of glycated hemoglobin, so the worse the blood sugar control, the lower the VR.

Blood pressure response analysis

Assess sympathetic nerve function through blood pressure response patterns.

Normal response: In phase 2, blood pressure is partially restored to baseline level by sympathetic nerve activity (IIb blood pressure recovery), and in phase 4, blood pressure overshoot occurs.

Adrenergic failure pattern: In phase 2, blood pressure does not return to baseline and continues to fall (loss of recovery in IIb blood pressure), and there is no excessive increase in blood pressure in phase 4. This pattern is observed in pure autonomic failure, multiple system atrophy, and diabetic autonomic neuropathy.

Inspection Procedure

To prepare for the test, it is recommended to perform the test after resting for at least 30 minutes, and to fast for at least 2 hours and quit smoking before the test. Connect a continuous blood pressure measuring device (Finometer or Portapres) to the electrocardiogram. When performing the maneuver, maintain a pressure of 40 mmHg for 15 seconds using a sheet or mouthpiece. Perform at least twice to check reproducibility.

It is contraindicated in situations where a severe increase in intra-abdominal pressure may be a problem (recent surgery, eye disease, suspected increase in intracranial pressure).

clinical application

The Valsalva test plays a key role in the diagnosis and severity assessment of diabetic cardiac autonomic neuropathy. Among the five standard autonomic function tests recommended by the ADA guidelines, the Valsalva maneuver is a representative test that simultaneously evaluates VR (parasympathetic nerve) and blood pressure response (sympathetic nerve).

It is also useful in evaluating POTS (orthostatic tachycardia syndrome). Abnormalities in the sympathetic response pattern during the Valsalva maneuver are observed in some POTS patients. It is also used to differentiate autonomic nerve involvement in multiple system atrophy and Parkinson's disease.

QUESTIONS

Frequently asked questions

Q01What is the Valsalva test?

The Valsalva maneuver is to close your mouth or nose and exhale strongly (a movement that increases abdominal pressure). The Valsalva maneuver measures how heart rate and blood pressure change during and immediately after holding this movement at a constant pressure (40 mmHg) for 15 seconds. Analyzing this pattern of change allows us to assess how normally the sympathetic and parasympathetic nervous systems are functioning.

Q02What can you learn from the Valsalva test?

We analyze the pattern in which the heart rate speeds up during the Valsalva maneuver (sympathetic response) and slows down when it stops (parasympathetic response). If your heart rate ratio (Valsalva ratio) is lower than normal, it indicates parasympathetic dysfunction. If blood pressure does not return to normal immediately after manipulation, it suggests sympathetic nerve dysfunction. It is used for diagnosis and severity assessment of various diseases such as diabetic autonomic neuropathy, autonomic failure, and autonomic nerve involvement in Parkinson's disease.

Q03How is the Valsalva test performed?

Get plenty of rest before the test, and avoid caffeine or certain cardiovascular drugs before starting the test. Connect a device that continuously measures blood pressure and heart rate in a lying or sitting position. Place your mouth on a special mouthpiece, maintain a pressure of 40 mmHg, and perform strong exhalation movements for 15 seconds. Continuously record changes in heart rate and blood pressure for 1 to 2 minutes during and immediately after movement. Typically, measurements are repeated 2 to 3 times to check reproducibility.

Q04Isn’t the Valsalva test dangerous?

It is a safe test for healthy people. However, caution is required in some situations. It is contraindicated or should be used with caution in cases such as recent myocardial infarction, unstable angina, serious arrhythmia, aortic dissection or aneurysm, retinal detachment, immediately after an acute stroke, or after eye surgery. There is no need to worry as the medical team will check your suitability before the test.

Q05What is the role of the Valsalva test in the autonomic test battery?

The autonomic nerve function battery is a comprehensive evaluation of sympathetic and parasympathetic nerve functions by performing several tests together. The Valsalva test is a core item of the autonomic nerve battery along with heart rate variability test, standing tilt test, and deep breathing test. In particular, both heart rate and blood pressure can be evaluated simultaneously, providing the most information in a single test. It is recommended as a standard test in autonomic evaluation by the American Academy of Neurology and the American Diabetes Association guidelines.

This article provides general medical information and does not replace an individual diagnosis or treatment plan. Please seek a medical assessment if symptoms persist.

Request a consultation